BFA
ASPX

BlackRock Fund Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BlackRock Fund Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-675,306
Closed -$67.7M – 3985
2015
Q1 		$67.7M Buy
675,306
+92,540
+16% +$6.16M 0.02% 1296
2014
Q4 		$30.6M Buy
582,766
+361,670
+164% +$10.6M 0.01% 1808
2014
Q3 		$5.68M Buy
221,096
+18,246
+9% +$388K ﹤0.01% 2678
2014
Q2 		$4.52M Sell
202,850
-18,179
-8% -$398K ﹤0.01% 2895
2014
Q1 		$6.8M Buy
+221,029
New +$5.94M ﹤0.01% 2630

BlackRock Fund Advisors's ASPX Position: Q2 2015 in Review

BlackRock Fund Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 675,306 shares — an estimated $67.7M sold.

BlackRock Fund Advisors first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $67.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BlackRock Fund Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 675,306 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $67.7M.
  • BlackRock Fund Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • BlackRock Fund Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $67.7M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.